targeted radiation therapy

PROCEDURE2 trials

Sponsors

University of Tennessee, The Second Affiliated Hospital of Dalian Medical University

Conditions

ES-SCLCParanasal Sinus Neoplasms

Phase 2

Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy and Sequential Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer

Not yet recruitingNCT07349225

The Second Affiliated Hospital of Dalian Medical UniversityES-SCLC

Start: 2026-01-31End: 2028-02-28Target: 46Updated: 2026-01-16

Unknown Phase

Chemoradiotherapy Followed by Surgery for Advanced Paranasal Sinus Cancer

WithdrawnNCT00347256

University of TennesseeParanasal Sinus Neoplasms

Target: 60Updated: 2008-12-10